A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ALXO shares is 172, representing N/A of the company's common stock.

Logos Global Management LP, in the last quarter, reduced its stake in ALXO by -5.26% restricting it's holding to 2.97 Million shares of worth nearly $33.49 Million. BlackRock Fund Advisors also lessened -1.87% of the ALXO shares from its portfolio, reducing its holding to 1.47 Million shares of worth $16.56 Million. Wellington Management Co. LLP also shunned ALXO shares holding by -59.85% last quarter which brought its holding to 1.13 Million shares worth $13.7 Million.

As per its latest 13F filing, Fidelity Management & Research Co increased its stake in ALXO by 16.17% in the last quarter. The institutional holder raised its holding to 4.63 Million shares having worth more than $52.18 Million. The Vanguard Group, Inc also added 6.10% more shares of ALXO to its portfolio, raising its holding to 1.38 Million shares of worth $15.57 Million. Cormorant Asset Management LP also increased its ALXO shares holding by 0% which brought its holding to 712.08 Thousands shares worth $8.03 Million.

The insider with the most stakes in ALXO is PONS JAUME , a President & CEO at the company. Additionally, ALXO stock is highly held by Director LETTMANN JASON and 10% Owner LSV ASSOCIATES, LLC among others.

Company executives, directors, and other insiders own 2.2 percent of ALX Oncology Holdings Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which ALXO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include

There have been no transaction(s) during the past 6-months in which ALXO insiders have bought stock N/A.

Around 896.5 Thousands ALX Oncology Holdings Inc. shares are held by insiders, which represents about 2.20% of ALXO Stock.

ALXO President & CEO, PONS JAUME holds the largest portfolio of the company's shares. ALXO shares owned by Levinson total nearly 539.75 Thousands.

Fidelity Management & Research Co is the largest institutional owner in ALXO which holds 4.63 Million shares worth $52.18 Million or 11.36% of the total ALXO shares outstanding followed by Logos Global Management LP with ownership of 2.97 Million shares representing 7.29% of the ALXO ownership. BlackRock Fund Advisors, Inc is the third largest stakeholder with 1.47 Million shares or 3.61% of the ownership worth more than $16.56 Million.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ALXO is concerned, it is a stock which is optionable.

Number of ALXO shares short as of 2022-10-13 was 4.4 Million. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 40.75 Million shares of ALXO are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ALXO has 30.01 Million shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ALXO was N/A as of 2022-10-13.